The Cannigma
JANUARY 13, 2023
Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. The study called out pinene, myrcene, and beta-caryophyllene as specifically useful terpenes.
FloridaMarijuana.net
OCTOBER 6, 2018
As researchers dive into the depths of the cannabinoid system it is becoming clear that cannabis terpenes are just as vital to a plant’s efficacy as are cannabinoids. Terpenes appear in abundance within nature, and it’s estimated that over 20,000 terpenes exist within our ecosystems. Paduch, Kandefer-Szersze?,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 2, 2021
Fragrant and terpene-heavy, these strains deserve all the glory, with no paper or glue detracting from the gorgeous essence of the herb.”. The first GRAV Reserve offerings include: GRAV Reserve Orange Mints (Hybrid) – THC 24.05% / Total Cannabinoids 29.03%, 5 mg/g Limonene, 3.5 Caryophyllene, 1.9 mg/g Linalool. mg/g Limonene, 3.5
Project CBD
JULY 12, 2023
It was once a common assumption within the cannabis community that plant cannabinoids aren’t “activated” or useful until they are “decarbed” — short for decarboxylated — which refers to the process of heating cannabis before it is consumed. But that notion has proven to be way off the mark.
FloridaMarijuana.net
JUNE 22, 2018
Ethan Russo suggested that Irritable Bowel Syndrome (IBS), along with fibromyalgia, migraine, and other related conditions, may be linked to an endocannabinoid deficiency ; treatable with cannabinoid medicine. Slowing down gut motility is not the only benefit that cannabis offers to people dealing with IBS.
Greencamp
AUGUST 16, 2018
Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. The first study I will reference is from 2006, conducted on mice.
Cannabis Law Report
JULY 12, 2019
International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.
Expert insights. Personalized for you.
132 
Let's personalize your content